Connect with us

Business

Third member of US FDA advisory panel resigns over Alzheimer’s drug approval – Fox Business

Published

on

Article feature image
ADVERTISEMENT

A third member of a panel of outside advisers to the U.S. Food and Drug Administration has resigned in protest over the agency’s decision to approve Biogen Inc’s Alzheimer’s disease treatment despite the committee’s recommendation against doing so.
Aaron…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
Tripadvisor launches service that it says offers bigger discounts on hotels, flights – CNBC
Article feature image
General Motors’ electric vehicle plan just got even more expensive – The Verge
Article feature image
Eight Royal Caribbean crew members test positive for COVID-19, delaying cruise – CBS News